Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin SR for Acute Bronchitis in Japan
NCT00360464Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of azithromycin in acute bronchitis and secondary infection, sponsored by Pfizer. Primary endpoint: Investigator's Clinical Efficacy at Day 8. Started Oct 2006; status: completed.
02
Drugs
azithromycin
03
Conditions
acute bronchitissecondary infection
Beyond the preview
Go deeper on NCT00360464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360464.